Answer
Worsening of asthma and dyspnea (shortness of breath) have been reported with tafluprost; their frequency cannot be estimated from the available data.
Sources for this answer
- SAFLUTAN 15 micrograms/ml eye drops, solution, in single-dose containerSanten UK Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked